[Rapid direct inhibition of thrombocyte receptors: Epifibatid additive in acute coronary syndromes. 65th Annual Meeting of the German Society for Cardiology and Cardiovascular Research. Mannheim, 8 April 1999].
D000208:Acute Disease; D003327:Coronary Disease / Q000188:drug therapy / Q000517:prevention & control*; D000077542:Eptifibatide; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy / Q000517:prevention & control; D010455:Peptides / Q000494:pharmacology / Q000627:therapeutic use; D015539:Platelet Activation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D019038:Platelet Glycoprotein GPIb-IX Complex; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface / Q000187:drug effects*
D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D019038:Platelet Glycoprotein GPIb-IX Complex; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface; C032193:glycoprotein receptor GPIb-IX; D000077542:Eptifibatide